Achim Mueller

1.2k total citations
21 papers, 873 citations indexed

About

Achim Mueller is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Organic Chemistry. According to data from OpenAlex, Achim Mueller has authored 21 papers receiving a total of 873 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 10 papers in Physiology and 1 paper in Organic Chemistry. Recurrent topics in Achim Mueller's work include Chronic Obstructive Pulmonary Disease (COPD) Research (16 papers), Asthma and respiratory diseases (10 papers) and Respiratory Support and Mechanisms (9 papers). Achim Mueller is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (16 papers), Asthma and respiratory diseases (10 papers) and Respiratory Support and Mechanisms (9 papers). Achim Mueller collaborates with scholars based in United States, Germany and United Kingdom. Achim Mueller's co-authors include J.A. van Noord, Wim Janssens, Jan Verhaert, P. J. G. Cornelissen, Joseph Aumann, J.J. Smeets, J. Aumann, Bernd Disse, Piet J.G. Cornelissen and Wayne F. March and has published in prestigious journals such as CHEST Journal, European Respiratory Journal and Thorax.

In The Last Decade

Achim Mueller

21 papers receiving 832 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Achim Mueller United States 11 784 631 30 26 26 21 873
Jacques P.H.M. Creemers Netherlands 12 476 0.6× 444 0.7× 28 0.9× 51 2.0× 21 0.8× 18 635
M. Reza Maleki-Yazdi Canada 11 575 0.7× 464 0.7× 13 0.4× 9 0.3× 7 0.3× 21 610
Simon Ward United Kingdom 11 499 0.6× 175 0.3× 100 3.3× 17 0.7× 25 1.0× 16 634
Lesley Towse United Kingdom 8 1.1k 1.4× 907 1.4× 8 0.3× 8 0.3× 36 1.4× 12 1.1k
Fronke Gerken Germany 7 901 1.1× 629 1.0× 4 0.1× 9 0.3× 18 0.7× 8 925
A Hasani United Kingdom 13 556 0.7× 173 0.3× 16 0.5× 4 0.2× 30 1.2× 29 684
Jeff A. Regnis Australia 11 539 0.7× 142 0.2× 11 0.4× 3 0.1× 21 0.8× 14 595
Eric Derom Belgium 13 343 0.4× 299 0.5× 18 0.6× 38 1.5× 3 0.1× 25 452
Demet Inci Switzerland 11 161 0.2× 152 0.2× 180 6.0× 16 0.6× 10 0.4× 17 491
Natalia Celejewska‐Wójcik Poland 12 157 0.2× 205 0.3× 13 0.4× 4 0.2× 11 0.4× 31 311

Countries citing papers authored by Achim Mueller

Since Specialization
Citations

This map shows the geographic impact of Achim Mueller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Achim Mueller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Achim Mueller more than expected).

Fields of papers citing papers by Achim Mueller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Achim Mueller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Achim Mueller. The network helps show where Achim Mueller may publish in the future.

Co-authorship network of co-authors of Achim Mueller

This figure shows the co-authorship network connecting the top 25 collaborators of Achim Mueller. A scholar is included among the top collaborators of Achim Mueller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Achim Mueller. Achim Mueller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ferguson, Gary T., et al.. (2020). <p>Effect of Inhaled Corticosteroid Withdrawal on Chronic Obstructive Pulmonary Disease Exacerbations in Patients Taking Triple Therapy at Baseline</p>. International Journal of COPD. Volume 15. 2879–2888. 4 indexed citations
2.
Calverley, Peter M.A., Antonio Anzueto, Daniel Dusser, et al.. (2018). Treatment of exacerbations as a predictor of subsequent outcomes in patients with COPD. International Journal of COPD. Volume 13. 1297–1308. 16 indexed citations
3.
Tashkin, Donald P., Marc Miravitlles, Bartolomé R. Celli, et al.. (2018). Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: a matched-subgroup post hoc analysis of the UPLIFT® trial. Respiratory Research. 19(1). 196–196. 17 indexed citations
4.
Watz, Henrik, Kay Tetzlaff, H Magnussen, et al.. (2018). Spirometric changes during exacerbations of COPD: a post hoc analysis of the WISDOM trial. Respiratory Research. 19(1). 251–251. 38 indexed citations
5.
Beck, Ekkehard, Dennis E. Doherty, ER Bleecker, et al.. (2018). Tiotropium Respimat®: efficacy in elderly asthma patients. Pneumologie. 72(S 01). S32–S33. 1 indexed citations
6.
Calverley, Peter M.A., Kay Tetzlaff, Daniel Dusser, et al.. (2017). Determinants of exacerbation risk in patients with COPD in the TIOSPIR study. International Journal of COPD. Volume 12. 3391–3405. 35 indexed citations
7.
Zhong, Nanshan, Hwa Sik Moon, Aziah Ahmad Mahayiddin, et al.. (2016). TIOtropium Safety and Performance In Respimat® (TIOSPIRTM): Analysis of Asian cohort of COPD patients. Respirology. 21(8). 1397–1403. 11 indexed citations
8.
Anzueto, Antonio, Peter M.A. Calverley, Robert A. Wise, et al.. (2016). Assessing COPD profiles and outcomes by dyspnoea severity. PA4057–PA4057. 2 indexed citations
9.
Dahl, Ronald, Peter M.A. Calverley, Antonio Anzueto, et al.. (2015). Safety and efficacy of tiotropium in patients switching from HandiHaler to Respimat in the TIOSPIR trial. BMJ Open. 5(12). e009015–e009015. 8 indexed citations
10.
Wise, Robert A., et al.. (2015). Investigator-reported vs adjudicated cause of death in the TIOSPIR™ trial. PA1498–PA1498. 1 indexed citations
11.
Wise, Robert A., Peter M.A. Calverley, Ronald Dahl, et al.. (2014). P261 Tiotropium Safety And Performance In Respimat(R) (tiospir ): Safety And Efficacy In Patients Naive To Treatment With Anticholinergics. Thorax. 69(Suppl 2). A192–A192. 1 indexed citations
12.
Noord, J.A. van, Joseph Aumann, Wim Janssens, et al.. (2010). Combining tiotropium and salmeterol in COPD: Effects on airflow obstruction and symptoms. Respiratory Medicine. 104(7). 995–1004. 83 indexed citations
13.
Noord, J.A. van, et al.. (2008). The efficacy of tiotropium administered via Respimat® Soft Mist™ Inhaler or HandiHaler® in COPD patients. Respiratory Medicine. 103(1). 22–29. 79 indexed citations
14.
Noord, J.A. van, Joseph Aumann, Wim Janssens, et al.. (2006). Effects of Tiotropium With and Without Formoterol on Airflow Obstruction and Resting Hyperinflation in Patients With COPD. CHEST Journal. 129(3). 509–517. 210 indexed citations
15.
16.
Noord, J.A. van, J. Aumann, Wim Janssens, et al.. (2005). Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD. European Respiratory Journal. 26(2). 214–222. 255 indexed citations
17.
Noord, J.A. van, J. Aumann, Wim Janssens, et al.. (2005). Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD. 1(2). 64–65. 40 indexed citations
18.
March, Wayne F., et al.. (2004). Clinical Trial of a Noninvasive Contact Lens Glucose Sensor. Diabetes Technology & Therapeutics. 6(6). 782–789. 56 indexed citations
19.
Baenziger, O., Achim Mueller, Jurg L. Jaggi, et al.. (1999). Cerebral blood flow and neurological outcome in the preterm infant. European Journal of Pediatrics. 158(2). 138–143. 10 indexed citations
20.
Mueller, Achim. (1960). [The aortic wall deserves special attention].. PubMed. 16. 210–20. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jacques P.H.M. Creemers Breakdown of academic impact, for papers by M. Reza Maleki-Yazdi Breakdown of academic impact, for papers by Simon Ward Breakdown of academic impact, for papers by Lesley Towse Breakdown of academic impact, for papers by Fronke Gerken Breakdown of academic impact, for papers by A Hasani Breakdown of academic impact, for papers by Jeff A. Regnis Breakdown of academic impact, for papers by Eric Derom Breakdown of academic impact, for papers by Demet Inci Breakdown of academic impact, for papers by Natalia Celejewska‐Wójcik
Rankless by CCL
2026